Is ArriVent BioPharma, Inc. (AVBP) a Buy, Sell, or Hold?
NASDAQ : AVBP
ArriVent BioPharma, Inc. — Analyst Ratings
$31.61 USD
-$0.12 (-0.38%)
- Volume
- 239.51K
- Average Volume
- 563.48K
- Market Capitalization
- $1.47B
- P/E Ratio
- -8.95
- Dividend Yield
- 0.00%
- Price Target
- $45.00
- Year High
- $35.83
- Year Low
- $16.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.95
Analyst Consensus Summary
Consensus Rating
Sell
7 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-29.8%
vs Current Price
Price Target
$45.00
Average TargetPrice Target Range
Lowest Target
$45.00
-29.8% DOWNSIDE
Average Target
$45.00
Median Estimate
Highest Target
$45.00
-29.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 7
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 7 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Goldman Sachs | Corinne Johnson | $33 | $22.03 | 2025-07-10 05:03 AM | 49.8% |
| Citigroup | Yigal Nochomovitz | $36 | $27.925 | 2024-09-10 07:49 AM | 28.9% |
| H.C. Wainwright | Robert Burns | $36 | $28.035 | 2024-09-10 02:38 AM | 28.4% |
| H.C. Wainwright | Robert Burns | $30 | $23.62 | 2024-08-16 02:39 AM | 27.0% |
| Oppenheimer | Jeff Jones | $35 | $18.77 | 2024-07-22 03:05 AM | 86.5% |